Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Predictive Oncology Inc. leverages artificial intelligence and a proprietary biobank of over 150,000 tumor samples to support cancer drug discovery and development. The company provides AI-driven predictive models, tumor-specific 3D cell culture models, and clinical tumor profiling tests. Its core markets include biopharmaceuticals, diagnostics, and healthcare providers, focusing on improving drug success rates, personalized treatments, and efficient oncology research.
This description was generated via AI from an annual report. Updated about 1 year ago.